Related Experiment Video
Updated: Jan 12, 2026

Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
Smart Inhalation Therapy: Boosting siRNA Efficacy with Inulin-Based Multifunctional Polymers.
Salvatore E Drago1, Marta Cabibbo1, Cinzia Scialabba1
1Lab of Biocompatible Polymers, Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Via Archirafi 32, Palermo 90123, Italy.
A novel inulin-based copolymer effectively delivers small interfering RNA (siRNA) via inhalation for treating lung diseases. This advanced delivery system overcomes biological barriers, enabling efficient gene silencing in the airway epithelium.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Gene Therapy
Background:
- Pulmonary diseases require effective siRNA delivery platforms to overcome lung barriers.
- Current methods struggle with efficient gene silencing in the airway epithelium.
Purpose of the Study:
- To synthesize and characterize a novel inulin-based copolymer for siRNA inhalation delivery.
- To evaluate the copolymer's potential as an effective carrier for pulmonary gene therapy.
Main Methods:
- Stepwise synthesis of an inulin (INU)-based copolymer, INU-VS-g-(PMeOx; bAPAE).
- Formation and characterization of siRNA polyplexes, including size, stability, and muco-diffusivity.
- Assessment of buffering capacity, endosomal escape, cytocompatibility, and gene silencing efficacy.
Main Results:
- Stable siRNA polyplexes (<30 nm) formed at low polymer/siRNA ratios (R=5).
- Polyplexes demonstrated efficient buffering, pH-dependent membrane destabilization, and mucus penetration.
- High cytocompatibility (>80% viability) and successful siRNA-mediated gene silencing were observed.
Conclusions:
- The inulin-based copolymer INU-VS-g-(PMeOx; bAPAE) is a promising siRNA carrier for pulmonary administration.
- Its properties facilitate overcoming lung barriers and achieving gene silencing.
- This highlights potential for treating respiratory diseases through advanced inhalation therapy.
More Related Videos
15:55Long-term Silencing of Intersectin-1s in Mouse Lungs by Repeated Delivery of a Specific siRNA via Cationic Liposomes. Evaluation of Knockdown Effects by Electron Microscopy
Published on: June 21, 2013
07:55Intratracheal Administration of Dry Powder Formulation in Mice
Published on: July 25, 2020
Related Concept Videos
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Inhaled Medications
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Bioavailability Enhancement: Drug Permeability Enhancement